| Drug Name |
Bromfenac sodium |
| Drug ID |
BADD_D00301 |
| Description |
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool to optimize surgical outcomes. |
| Indications and Usage |
For the treatment of postoperative inflammation in patients who have undergone cataract extraction. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
S01BC11 |
| DrugBank ID |
DB00963
|
| KEGG ID |
D03163
|
| MeSH ID |
C053083
|
| PubChem ID |
23693301
|
| TTD Drug ID |
D0U1OM
|
| NDC Product Code |
12817-990; 14445-008; 71052-021; 24208-602; 50384-0150; 42973-144; 80988-0365; 46144-310 |
| Synonyms |
bromfenac | ISV-303 | Duract | sodium bromfenac | bromfenac sodium | Xibrom | AHR-10282 |
